J. Pérodin

发表

What can angiotensin antagonists do that converting-enzyme inhibition can't: the case of post-angioplastic restenosis.

E. Escher, S. Laporte, D. Pham, 1996, Canadian journal of physiology and pharmacology.

Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.

R. Leduc, E. Escher, G. Guillemette, 2002, Biochemistry.

Improved Activity of a New Angiotensin Receptor Antagonist by an Injectable Spray-Dried Polymer Microsphere Preparation

N. Phillips, P. Hildgen, J. N. Mcmullen, 1997, Pharmaceutical Research.

PAF activation of a voltage‐gated R‐type Ca2+ channel in human and canine aortic endothelial cells

J. Stankova, M. Rola-Pleszczynski, J. Pérodin, 1993, British journal of pharmacology.

Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia

M. Karyana, H. Kosasih, J. Pérodin, 2022, Frontiers in Medicine.

Lipid Masking and Reactivation of Angiotensin Analogues

E. Escher, L. Maletínská, D. Pham, 1996 .

N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor.

E. Escher, G. Guillemette, R. Bouley, 1998, European journal of pharmacology.

Characterization of a specific binding site for angiotensin II in chicken liver.

M. Arcand, G. Servant, E. Escher, 1997, Canadian journal of physiology and pharmacology.

Assays for radiolabel-photoaffinity labeling of Angiotensin receptors.

R. Leduc, E. Escher, G. Guillemette, 2001, Methods in molecular medicine.

Structure-activity relationship of the agonist-antagonist transition on the type 1 angiotensin II receptor; the search for inverse agonists.

R. Leduc, E. Escher, R. Bouley, 1996, Advances in experimental medicine and biology.

Angiotensin II Analogues with Sulphur-containing Side-chains in Position 5

E. Escher, R. Bouley, P. Cordopatis, 2000, Arzneimittelforschung.

METHIONINE PROXIMITY ASSAY, A NOVEL METHOD FOR EXPLORING PEPTIDE LIGAND–RECEPTOR INTERACTION

R. Leduc, E. Escher, G. Guillemette, 2002, Journal of receptor and signal transduction research.

Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form.

R. Leduc, E. Escher, G. Guillemette, 2002, Canadian journal of physiology and pharmacology.

Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications.

G. Marshall, G. Nikiforovich, E. Escher, 1996, Journal of medicinal chemistry.

The Active and the Inactive Form of the hAT1 Receptor Have an Identical Ligand-Binding Environment: An MPA Study on a Constitutively Active Angiotensin II Receptor Mutant

R. Leduc, E. Escher, G. Guillemette, 2006, Journal of receptor and signal transduction research.